Search

Search for
Advanced filters
Keyword(s)	Delete

Additional Search Options (click to show) Additional Search Options (click to hide)

Search categories
Authors
Title
Abstract
Full Text
Search in PDF
Supplementary File(s)
Publication Date
From
Until
Index terms
Discipline(s)
Type (method/approach)
Coverage
All index term fields

Issue

Title

Authors

Vol 25, No 6 (2025)

Capivasertib: First Approved AKT inhibitor for the Treatment of Patients with Breast Cancer

De S.

(Eng)

Vol 10, No 9 (2010)

Targeted Therapies in Metastatic Melanoma: Toward a Clinical Breakthrough?

Julia F., Thomas L., Dumontet C., Dalle S.

(Eng)

Vol 11, No 8 (2011)

Therapeutic Strategies to Target Multiple Kinases in Glioblastoma

Sathornsumetee S.

(Eng)

Vol 11, No 3 (2011)

BRAF as a Target for Cancer Therapy

Dienstmann R., Tabernero J.

(Eng)

Vol 15, No 8 (2015)

5-Lipoxygenase and Cyclooxygenase Inhibitory Dammarane Triterpenoid 1 from Borassus flabellifer Seed Coat Inhibits Tumor Necrosis Factor-α Secretion in LPSInduced THP-1 Human Monocytes and Induces Apoptosis in MIA PaCa-2 Pancreatic Cancer Cells

Sastry Yarla N., Azad R., Basha M., Rajack A., Kaladhar D.S., Kumar Allam B., Rao. Pragada R., Nand Singh K., Kumari K S., Pallu R., Parimi U., Bishayee A., Rao. Duddukuri G.

(Eng)

Vol 14, No 5 (2014)

Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer

Passaro A., Alesini D., Pochesci A., Cortesi E.

(Eng)

Vol 12, No 9 (2012)

JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation?

P. S. Santos F., Verstovsek S.

(Eng)

Vol 12, No 3 (2012)

Melanoma and Epigenetic Treatment: Past and Future

AM La Porta C.

(Eng)

Vol 11, No 1 (2011)

Metal-Based Inhibitors of Protein Tyrosine Phosphatases

Lu L., Zhu M.

(Eng)

Vol 10, No 4 (2010)

Latest Insights into the Anticancer Activity of Gold(III)-Dithiocarbamato Complexes

Ronconi L., Aldinucci D., Ping Dou Q., Fregona D.

(Eng)

Vol 15, No 7 (2015)

Current Molecularly Targeting Therapies in NSCLC and Melanoma

Rajanna S., Rastogi I., Wojdyla L., Furo H., Kulesza A., Lin L., Sheu B., rakes M., Ivanovich M., Puri N.

(Eng)

Vol 14, No 1 (2014)

The Microarray Gene Profiling Analysis of Glioblastoma Cancer Cells Reveals Genes Affected by FAK Inhibitor Y15 and Combination of Y15 and Temozolomide

Huang G., Ho B., Conroy J., Liu S., Qiang H., Golubovskaya V.

(Eng)

Vol 12, No 8 (2012)

In Vitro Synergistic Interaction between DTA0100 and Radiation in Human Cancer Cell Lines

Bordon E., G. Leon L., Rios-Luci C., C. Lara P., M. Padron J.

(Eng)

Vol 12, No 10 (2012)

Developing Phytoestrogens for Breast Cancer Prevention

M. Liu M., Huang Y., Wang J.

(Eng)

Vol 10, No 3 (2010)

New Medical Strategies for Midgut Carcinoids

Nilsson O., Arvidsson Y., Johanson V., Forssell-Aronsson E., Ahlman H.

(Eng)

Vol 25, No 1 (2025)

Targeting RSK2 in Cancer Therapy: A Review of Natural Products

Wu T., Chen Z., Liu X., Wu X., Wang Z., Guo W.

(Eng)

Vol 15, No 4 (2015)

Small Molecules for Immunomodulation in Cancer: A Review

Iyer V.

(Eng)

Vol 13, No 5 (2013)

Targeting the Fibroblast Growth Factor Receptors for the Treatment of Cancer

Lemieux S., Hadden M.

(Eng)

Vol 12, No 7 (2012)

The Cytotoxic Effect of Emetine and CGP-74514A Studied with the Hollow Fiber Model and ArrayScan Assay in Neuroendocrine Tumors In Vitro

E. Larsson D., B. Hassan S., Oberg K., Granberg D.

(Eng)

Vol 12, No 1 (2012)

New Targeted Therapies for Anaplastic Thyroid Cancer

Antonelli A., Fallahi P., Ulisse S., Martina Ferrari S., Minuto M., Saraceno G., Santini F., Mazzi V., D'Armiento M., Miccoli P.

(Eng)

Vol 10, No 7 (2010)

Updates of mTOR Inhibitors

Zhou H., Luo Y., Huang S.

(Eng)

Vol 10, No 3 (2010)

Anaplastic Lymphoma Kinase as a Therapeutic Target in Anaplastic Large Cell Lymphoma, Non-Small Cell Lung Cancer and Neuroblastoma

Cheng M., R. Ott G.

(Eng)

Vol 23, No 14 (2023)

Novel Arcyriaflavin-A Derivatives as PIM Kinase Inhibitors for Treating Cancer

De S.

(Eng)

Vol 15, No 3 (2015)

Marizomib, A Potent Second Generation Proteasome Inhibitor from Natural Origin

Ma L., Diao A.

(Eng)

Vol 13, No 4 (2013)

FAK and Nanog Cross Talk with p53 in Cancer Stem Cells

M. Golubovskaya V.

(Eng)

Vol 12, No 7 (2012)

MMPs in Ovarian Cancer as Therapeutic Targets

Karam A., Dorigo O.

(Eng)

Vol 11, No 9 (2011)

Ceramidases in Hematological Malignancies: Senseless or Neglected Target?

Fabrias G., Bedia C., Casas J., Luis Abad J., Delgado A.

(Eng)

Vol 10, No 7 (2010)

STAT3 as a Therapeutic Target for Glioblastoma

Liu Y., Li C., Lin J.

(Eng)

Vol 10, No 10 (2010)

Focal Adhesion Kinase as a Therapeutic Target of Bortezomib

Ko B., Chang T., Liou J.

(Eng)

Vol 13, No 2 (2013)

A Natural Anticancer Agent Thaspine Targets Human Topoisomerase IB

Castelli S., Katkar P., Vassallo O., Falconi M., Linder S., Desideri A.

(Eng)

Vol 15, No 2 (2015)

Design, Synthesis and Biological Evaluation of Quinoxalin-2(1H)-one Derivatives as EGFR Tyrosine Kinase Inhibitors

Qin X., Han X., Hu L., Li Z., Geng Z., Wang Z., Zeng C., Xiao X.

(Eng)

Vol 13, No 3 (2013)

Cytotoxicity and Cell Death Mechanisms Induced by a Novel Bisnaphthalimidopropyl Derivative against the NCI-H460 non-small Lung Cancer Cell Line

T. Lima R., A. Barron G., A. Grabowska J., Bermano G., Kaur S., Roy N., Helena Vasconcelos M., K.T. Lin P.

(Eng)

Vol 12, No 7 (2012)

Novel Strategies for Hepatocellular Carcinoma Based on MMPs Science

Okazaki I., Inagaki Y.

(Eng)

Vol 10, No 6 (2010)

Mouse Induced Glioma-Initiating Cell Models and Therapeutic Targets

Kondo T.

(Eng)

Vol 10, No 10 (2010)

Focal Adhesion Kinase as a Cancer Therapy Target

M. Golubovskaya V.

(Eng)

Vol 14, No 1 (2014)

The Microarray Gene Profiling Analysis of Glioblastoma Cancer Cells Reveals Genes Affected by FAK Inhibitor Y15 and Combination of Y15 and Temozolomide

Huang G., Ho B., Conroy J., Liu S., Qiang H., Golubovskaya V.

(Eng)

Vol 14, No 8 (2014)

A Steroidal Na+/K+ ATPase Inhibitor Triggers Pro-apoptotic Signaling and Induces Apoptosis in Prostate and Lung Tumor Cells

Honisch S., Alkahtani S., Kounenidakis M., Liu G., Alarifi S., Al-Yahya H., Dimas K., AlKahtane A., Prousis K., Al-Dahmash B., Calogeropoulou T., Alevizopoulos K., Lang F., Stournaras C.

(Eng)

Vol 13, No 2 (2013)

The Therapeutical Potential of a Novel Pterocarpanquinone LQB-118 to Target Inhibitor of Apoptosis Proteins in Acute Myeloid Leukemia Cells

R. de Souza Reis F., C. Casal de Faria F., P. Castro C., S. de Souza P., da Cunha Vasconcelos F., D. Bello R., J. da Silva A., R.R. Costa P., C. Maia R.

(Eng)

Vol 12, No 7 (2012)

Modulation of MMPs by Cell Surface Integrin Receptor α5β1

Pal S., Kumar Ganguly K., Moulik S., Chatterjee A.

(Eng)

Vol 11, No 7 (2011)

Nitroimidazoles as Anti-Tumor Agents

Liu K., Zhu H.

(Eng)

Vol 10, No 6 (2010)

Exploiting Cyclooxygenase-(in)Dependent Properties of COX-2 Inhibitors for Malignant Glioma Therapy

H. Schonthal A.

(Eng)

Vol 10, No 1 (2010)

Hepatocyte Growth Factor Activation Inhibitors – Therapeutic Potential in Cancer

Parr C., Sanders A., Jiang W.

(Eng)

Vol 24, No 15 (2024)

Synthesis and Molecular Dynamic Simulation of Novel Cationic and Non-cationic Pyrimidine Derivatives as Potential G-quadruplex-ligands

Atapour-Mashhad H., Soukhtanloo M., Golmohammadzadeh S., Chamani J., Nejabat M., Hadizadeh F.

(Eng)

Vol 14, No 7 (2014)

Hypersensitivity to Aurora Kinase Inhibitors in Cells Resistant against Platinum- Containing Anticancer Agents

Akiyama M., Izumi H., Wang K., Yamaguchi T., Kuma A., Kitamura N., Harada Y., Oya R., Yamaguchi K., Iwai Y., Kohno K.

(Eng)

Vol 13, No 10 (2013)

Natural Compounds with Cell Growth Inhibitory Activity in Human Tumor Cell Lines

Cazal C., Choosang K., Severino V., Fernandes J., Silva M., Vieira P., Nascimento M., Almeida G., Vasconcelos M., Pakkong P., Pinto M.

(Eng)

Vol 12, No 7 (2012)

RECKing MMP: Relevance of Reversion-inducing Cysteine-rich Protein with Kazal Motifs as a Prognostic Marker and Therapeutic Target for Cancer (A Review)

Nagini S.

(Eng)

Vol 10, No 6 (2010)

Therapeutic Exploitation of Apoptosis and Autophagy for Glioblastoma

Kogel D., Fulda S., Mittelbronn M.

(Eng)

Vol 10, No 1 (2010)

An Orally Bioavailable c-Met Kinase Inhibitor Potently Inhibits Brain Tumor Malignancy and Growth

Guessous F., Zhang Y., diPierro C., Marcinkiewicz L., Sarkaria J., Schiff D., Buchanan S., Abounader R.

(Eng)

Vol 16, No 10 (2016)

Inhibitors of Cancer Stem Cells

García-Rubiño M., Lozano-López C., Campos J.

(Eng)

Vol 14, No 6 (2014)

Preclinical Development of Novel Rac1-GEF Signaling Inhibitors using a Rational Design Approach in Highly Aggressive Breast Cancer Cell Lines

Cardama G., Comin M., Hornos L., Gonzalez N., Defelipe L., Turjanski A., Alonso D., Gomez D., Menna P.

(Eng)

Vol 12, No 9 (2012)

Methylenedioxy- and Ethylenedioxy-Fused Indolocarbazoles: Potent Human Topoisomerase I Inhibitors and Antitumor Agents

E. Zembower D., Xie Y., Koohang A., J. Kuffel M., M. Ames M., Zhou Y., Mishra R., Aye Mar A., T. Flavin M., Xu Z.

(Eng)

Vol 12, No 7 (2012)

Introduction: MMPs, ADAMs/ADAMTSs Research Products to Achieve Big Dream

Okazaki I., Nabeshima K.

(Eng)

Vol 11, No 2 (2011)

The Ubiquitin+Proteasome Protein Degradation Pathway as a Therapeutic Strategy in the Treatment of Solid Tumor Malignancies

J. Driscoll J., Minter A., A. Driscoll D., K. Burris J.

(Eng)

Vol 10, No 5 (2010)

Enzyme Inhibition as a Key Target for the Development of Novel Metal-Based Anti-Cancer Therapeutics

Griffith D., P. Parker J., J. Marmion C.

(Eng)

Vol 10, No 1 (2010)

Discovery of Small Molecule c-Met Inhibitors: Evolution and Profiles of Clinical Candidates

Underiner T., Herbertz T., Miknyoczki S.

(Eng)

1 - 55 of 55 Items

Search tips:

Search terms are case-insensitive
Common words are ignored
By default only articles containing all terms in the query are returned (i.e., AND is implied)
Combine multiple words with OR to find articles containing either term; e.g., education OR research
Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Username
Password
Remember me

Forgot password?	Register

Username
Password
Remember me

Forgot password?	Register

Search

Advanced filters

Search categories

Publication Date

Index terms

Search tips: